2014
DOI: 10.1016/j.ejmech.2014.02.045
|View full text |Cite
|
Sign up to set email alerts
|

Design, synthesis and evaluation of genistein-O-alkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer's disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
49
0
1

Year Published

2014
2014
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 99 publications
(51 citation statements)
references
References 47 publications
1
49
0
1
Order By: Relevance
“…Generally, the N-2-methoxybenzyl groups indicated stronger inhibitory potency than N-benzyl groups. And the compounds possessing a N-ethyl group showed obviously better AChE inhibitory activity than the compounds with a N-methyl group, which was consistent with the previously reported results in our lab [22,23]. On the other hand, we also investigated the effects of the side chain length on inhibitory ability of AChE, the optimal chain length was four-methylene linker.…”
Section: Inhibition Of Ache and Buchesupporting
confidence: 89%
See 2 more Smart Citations
“…Generally, the N-2-methoxybenzyl groups indicated stronger inhibitory potency than N-benzyl groups. And the compounds possessing a N-ethyl group showed obviously better AChE inhibitory activity than the compounds with a N-methyl group, which was consistent with the previously reported results in our lab [22,23]. On the other hand, we also investigated the effects of the side chain length on inhibitory ability of AChE, the optimal chain length was four-methylene linker.…”
Section: Inhibition Of Ache and Buchesupporting
confidence: 89%
“…[23] Materials and animals Donepezil was purchased from Eisai China Inc. Scopolamine was purchase from J&K Scientific. light-dark cycle, a temperature and humidity controlled environment with access to food and water ad libitum.…”
Section: 211mentioning
confidence: 99%
See 1 more Smart Citation
“…Besides, a number of genistein derivatives have been reported as anti-AD agents in the past years ( Fig. 1) 12,13 . These results indicate that genistein could be used as leading compound for the treatment of AD.…”
Section: Introductionmentioning
confidence: 99%
“…8 Usually, the starting point for the design of such compounds is the structure of a known AChE inhibitor, which is linked to an antioxidant pharmacophoric moiety, [11][12][13][14][15][16][17][18] e.g. phenolics and polyphenolics derived fragments.…”
Section: Introductionmentioning
confidence: 99%